Potential side effects As with any treatment, there may be some potential side effects associated with CJC-1295 therapy
Given the high prevalence of fatty liver in diabetic patients (estimated at 5570%), initiating or switching to a GLP-1 agonist addresses both conditions simultaneously
Deficiencies in B12 can directly lead to nerve damage and worsen symptoms of diabetic neuropathy.65 While most people can get adequate B12 through diet (meat, fish, dairy, fortified cereals), certain medications including metformin and proton pump inhibitors can impair absorption and raise the risk of deficiency
Efficiency - the product package contains 30 portions of the product
Monitoring and Managing Treatment Under NHS Care Patients receiving GLP-1 receptor agonists require structured monitoring to ensure treatment safety, efficacy, and appropriate continuation